 | • レポートコード：MRC309Z7877 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界のHPV四価ワクチンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界のHPV四価ワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - HPV四価ワクチンの成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため HPV四価ワクチン市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・HPV6型、HPV11型、HPV16型、HPV18型 用途別セグメント ・がん予防、疾病予防 主要な市場プレーヤー ・Merck、GlaxoSmithKline、Sanofi、Serum Institute of India、CSL (Commonwealth Serum Laboratories) 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、HPV四価ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なHPV四価ワクチンメーカーの企業概要、2019年～2022年までのHPV四価ワクチンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なHPV四価ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別HPV四価ワクチンの販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までのHPV四価ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのHPV四価ワクチン市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、およびHPV四価ワクチンの産業チェーンを掲載しています。 ・第14、15章では、HPV四価ワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - HPV四価ワクチンの概要 - 種類別分析（2018年vs2022年vs2029年）：HPV6型、HPV11型、HPV16型、HPV18型 - 用途別分析（2018年vs2022年vs2029年）：がん予防、疾病予防 - 世界のHPV四価ワクチン市場規模・予測 - 世界のHPV四価ワクチン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Merck、GlaxoSmithKline、Sanofi、Serum Institute of India、CSL (Commonwealth Serum Laboratories) ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：HPV6型、HPV11型、HPV16型、HPV18型 ・用途別分析2018年-2029年：がん予防、疾病予防 ・HPV四価ワクチンの北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・HPV四価ワクチンのヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・HPV四価ワクチンのアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・HPV四価ワクチンの南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・HPV四価ワクチンの中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global HPV Quadrivalent Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
HPV Quadrivalent Vaccine is a vaccine that helps protect against four types of human papillomavirus (HPV) that can cause certain cancers and diseases. These four types are HPV 6, 11, 16, and 18, which are responsible for causing approximately 70% of cervical cancer cases and 90% of genital warts cases.
The upstream industry chain of the HPV Quadrivalent Vaccine includes the research and development of the vaccine, which involves the identification of the specific HPV strains and the creation of the vaccine formula. This is followed by the production of the vaccine, which involves the cultivation of the virus and the manufacturing of the vaccine itself. The downstream industry chain involves the distribution and administration of the vaccine to patients, which includes marketing, sales, and delivery.
This report is a detailed and comprehensive analysis for global HPV Quadrivalent Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global HPV Quadrivalent Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global HPV Quadrivalent Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global HPV Quadrivalent Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global HPV Quadrivalent Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for HPV Quadrivalent Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global HPV Quadrivalent Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, GlaxoSmithKline, Sanofi, Serum Institute of India and CSL (Commonwealth Serum Laboratories). etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
HPV Quadrivalent Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
HPV6 Type
HPV11 Type
HPV16 Type
HPV18 Type
Market segment by Application
Cancer Prevention
Disease Prevention
Major players covered
Merck
GlaxoSmithKline
Sanofi
Serum Institute of India
CSL (Commonwealth Serum Laboratories)
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe HPV Quadrivalent Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of HPV Quadrivalent Vaccine, with price, sales, revenue and global market share of HPV Quadrivalent Vaccine from 2018 to 2023.
Chapter 3, the HPV Quadrivalent Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the HPV Quadrivalent Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and HPV Quadrivalent Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of HPV Quadrivalent Vaccine.
Chapter 14 and 15, to describe HPV Quadrivalent Vaccine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of HPV Quadrivalent Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global HPV Quadrivalent Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 HPV6 Type
1.3.3 HPV11 Type
1.3.4 HPV16 Type
1.3.5 HPV18 Type
1.4 Market Analysis by Application
1.4.1 Overview: Global HPV Quadrivalent Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cancer Prevention
1.4.3 Disease Prevention
1.5 Global HPV Quadrivalent Vaccine Market Size & Forecast
1.5.1 Global HPV Quadrivalent Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global HPV Quadrivalent Vaccine Sales Quantity (2018-2029)
1.5.3 Global HPV Quadrivalent Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck HPV Quadrivalent Vaccine Product and Services
2.1.4 Merck HPV Quadrivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline HPV Quadrivalent Vaccine Product and Services
2.2.4 GlaxoSmithKline HPV Quadrivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GlaxoSmithKline Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi HPV Quadrivalent Vaccine Product and Services
2.3.4 Sanofi HPV Quadrivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sanofi Recent Developments/Updates
2.4 Serum Institute of India
2.4.1 Serum Institute of India Details
2.4.2 Serum Institute of India Major Business
2.4.3 Serum Institute of India HPV Quadrivalent Vaccine Product and Services
2.4.4 Serum Institute of India HPV Quadrivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Serum Institute of India Recent Developments/Updates
2.5 CSL (Commonwealth Serum Laboratories)
2.5.1 CSL (Commonwealth Serum Laboratories) Details
2.5.2 CSL (Commonwealth Serum Laboratories) Major Business
2.5.3 CSL (Commonwealth Serum Laboratories) HPV Quadrivalent Vaccine Product and Services
2.5.4 CSL (Commonwealth Serum Laboratories) HPV Quadrivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 CSL (Commonwealth Serum Laboratories) Recent Developments/Updates
3 Competitive Environment: HPV Quadrivalent Vaccine by Manufacturer
3.1 Global HPV Quadrivalent Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global HPV Quadrivalent Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global HPV Quadrivalent Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of HPV Quadrivalent Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 HPV Quadrivalent Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 HPV Quadrivalent Vaccine Manufacturer Market Share in 2022
3.5 HPV Quadrivalent Vaccine Market: Overall Company Footprint Analysis
3.5.1 HPV Quadrivalent Vaccine Market: Region Footprint
3.5.2 HPV Quadrivalent Vaccine Market: Company Product Type Footprint
3.5.3 HPV Quadrivalent Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global HPV Quadrivalent Vaccine Market Size by Region
4.1.1 Global HPV Quadrivalent Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global HPV Quadrivalent Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global HPV Quadrivalent Vaccine Average Price by Region (2018-2029)
4.2 North America HPV Quadrivalent Vaccine Consumption Value (2018-2029)
4.3 Europe HPV Quadrivalent Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific HPV Quadrivalent Vaccine Consumption Value (2018-2029)
4.5 South America HPV Quadrivalent Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa HPV Quadrivalent Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global HPV Quadrivalent Vaccine Sales Quantity by Type (2018-2029)
5.2 Global HPV Quadrivalent Vaccine Consumption Value by Type (2018-2029)
5.3 Global HPV Quadrivalent Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global HPV Quadrivalent Vaccine Sales Quantity by Application (2018-2029)
6.2 Global HPV Quadrivalent Vaccine Consumption Value by Application (2018-2029)
6.3 Global HPV Quadrivalent Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America HPV Quadrivalent Vaccine Sales Quantity by Type (2018-2029)
7.2 North America HPV Quadrivalent Vaccine Sales Quantity by Application (2018-2029)
7.3 North America HPV Quadrivalent Vaccine Market Size by Country
7.3.1 North America HPV Quadrivalent Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America HPV Quadrivalent Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe HPV Quadrivalent Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe HPV Quadrivalent Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe HPV Quadrivalent Vaccine Market Size by Country
8.3.1 Europe HPV Quadrivalent Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe HPV Quadrivalent Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific HPV Quadrivalent Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific HPV Quadrivalent Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific HPV Quadrivalent Vaccine Market Size by Region
9.3.1 Asia-Pacific HPV Quadrivalent Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific HPV Quadrivalent Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America HPV Quadrivalent Vaccine Sales Quantity by Type (2018-2029)
10.2 South America HPV Quadrivalent Vaccine Sales Quantity by Application (2018-2029)
10.3 South America HPV Quadrivalent Vaccine Market Size by Country
10.3.1 South America HPV Quadrivalent Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America HPV Quadrivalent Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa HPV Quadrivalent Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa HPV Quadrivalent Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa HPV Quadrivalent Vaccine Market Size by Country
11.3.1 Middle East & Africa HPV Quadrivalent Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa HPV Quadrivalent Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 HPV Quadrivalent Vaccine Market Drivers
12.2 HPV Quadrivalent Vaccine Market Restraints
12.3 HPV Quadrivalent Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of HPV Quadrivalent Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of HPV Quadrivalent Vaccine
13.3 HPV Quadrivalent Vaccine Production Process
13.4 HPV Quadrivalent Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 HPV Quadrivalent Vaccine Typical Distributors
14.3 HPV Quadrivalent Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer